On October 16, 2024, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced that it had filed the New Drug Application (NDA) for TNX-102 SL for the treatment of fibromyalgia. The FDA typically ...
The medical round will be conducted by the authorities to assess the visual standards of the candidates. As per the official notification, the corrected vision must be 6/6 in the better eye and 6/9 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback